Stevioside protects LPS-induced acute lung injury in mice

Inflammation

Volumn 36, Issue 1, 2013, Pages 242-250

  Yingkun, Nie ^a   Zhenyu, Wang ^a   Jing, Lin ^a   Xiuyun, Lu ^a   Huimin, Yu ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

acute lung injury; cytokine; lipopolysaccharide; stevioside

Indexed keywords

CYCLOOXYGENASE 2; DEXAMETHASONE; I KAPPA B; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MYELOPEROXIDASE; NITRATE; NITRITE; STEVIOSIDE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL COUNT; CONTROLLED STUDY; HISTOPATHOLOGY; LUNG LAVAGE; LUNG WEIGHT; MACROPHAGE; MALE; MOUSE; NEUTROPHIL COUNT; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ACUTE LUNG INJURY; ANIMALS; ANTI-INFLAMMATORY AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; CYCLOOXYGENASE 2; DEXAMETHASONE; DITERPENES, KAURANE; GLUCOSIDES; I-KAPPA B KINASE; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; LUNG; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; NEUTROPHILS; NF-KAPPA B; NITRATES; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; PEROXIDASE; PHOSPHORYLATION; RANDOM ALLOCATION; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

MUS; STEVIA REBAUDIANA;

EID: 84872968441     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-012-9540-8     Document Type: Article

References (31)

1. Lee, W.L., and G.P. Downey. 2001. Neutrophil activation and acute lung injury. Current Opinion in Critical Care 7: 1-7. (Pubitemid 32163422)
2. Puneet, P., S. Moochhala, and M. Bhatia. 2005. Chemokines in acute respiratory distress syndrome. American Journal of Physiology. Lung Cellular and Molecular Physiology 288: L3-L15. (Pubitemid 40023881)
3. Avecillas, J.F., A.X. Freire, and A.C. Arroliga. 2006. Clinical epidemiology of acute lung injury and acute respiratory distress syndrome: incidence, diagnosis, and outcomes. Clinics in Chest Medicine 27: 549-557. abstract vii. (Pubitemid 44666245)
4. Rubenfeld, G.D., E. Caldwell, E. Peabody, J. Weaver, D.P. Martin, et al. 2005. Incidence and outcomes of acute lung injury. The New England Journal of Medicine 353: 1685-1693. (Pubitemid 41464707)
5. Kristof, A.S., P. Goldberg, V. Laubach, and S.N. Hussain. 1998. Role of inducible nitric oxide synthase in endotoxin-induced acute lung injury. American Journal of Respiratory and Critical Care Medicine 158: 1883-1889. (Pubitemid 29008829)
6. Ware, L.B., and M.A. Matthay. 2000. The acute respiratory distress syndrome. The New England Journal of Medicine 342: 1334-1349. (Pubitemid 30408719)
7. Chan, P., B. Tomlinson, Y.J. Chen, J.C. Liu, M.H. Hsieh, et al. 2000. A double-blind placebo-controlled study of the effectiveness and tolerability of oral stevioside in human hypertension. British Journal of Clinical Pharmacology 50: 215-220.
8. Lee, C.N., K.L. Wong, J.C. Liu, Y.J. Chen, J.T. Cheng, et al. 2001. Inhibitory effect of stevioside on calcium influx to produce antihypertension. Planta Medica 67: 796-799. (Pubitemid 34015540)
9. Yasukawa, K., S. Kitanaka, and S. Seo. 2002. Inhibitory effect of stevioside on tumor promotion by 12-O-tetradecanoylphorbol-13-Acetate in two-stage carcinogenesis in mouse skin. Biological and Pharmaceutical Bulletin 25: 1488-1490. (Pubitemid 39663173)
10. Boonkaewwan, C., C. Toskulkao, and M. Vongsakul. 2006. Anti-inflammatory and immunomodulatory activities of stevioside and its metabolite steviol on THP-1 cells. Journal of Agricultural and Food Chemistry 54: 785-789. (Pubitemid 43274115)
11. Boonkaewwan, C., M. Ao, C. Toskulkao, and M.C. Rao. 2008. Specific immunomodulatory and secretory activities of stevioside and steviol in intestinal cells. Journal of Agricultural and Food Chemistry 56: 3777-3784. (Pubitemid 351860184)
12. Sun, S., H. Zhang, B. Xue, Y. Wu, J. Wang, et al. 2006. Protective effect of glutathione against lipopolysaccharide-induced inflammation and mortality in rats. Inflammation Research 55: 504-510. (Pubitemid 44826741)
13. Yi, C., Y. Cao, S.H. Mao, H. Liu, L.L. Ji, et al. 2009. Recombinant human growth hormone improves survival and protects against acute lung injury in murine Staphylococcus aureus sepsis. Inflammation Research 58: 855-862.
14. Yunhe, F., L. Bo, F. Xiaosheng, L. Fengyang, L. Dejie, et al. 2012. The effect of magnolol on the toll-like receptor 4/nuclear factor kappa B signaling pathway in lipopolysaccharide-induced acute lung injury in mice. European Journal of Pharmacology 689: 255-261.
15. Suda, K., M. Tsuruta, J. Eom, C. Or, T. Mui, et al. 2011. Acute lung injury induces cardiovascular dysfunction: effects of IL-6 and budesonide/formoterol. American Journal of Respiratory Cell and Molecular Biology 45: 510-516.
16. Wu, Y., M. Singer, F. Thouron, M. Alaoui-El-Azher, and L. Touqui. 2002. Effect of surfactant on pulmonary expression of type IIA PLA(2) in an animal model of acute lung injury. American Journal of Physiology. Lung Cellular and Molecular Physiology 282: L743-L750.
17. Bhatia, M., and S. Moochhala. 2004. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. The Journal of Pathology 202: 145-156. (Pubitemid 38208651)
18. Cribbs, S.K., M.A. Matthay, and G.S. Martin. 2010. Stem cells in sepsis and acute lung injury. Critical Care Medicine 38: 2379-2385.
19. Goodman, R.B., J. Pugin, J.S. Lee, and M.A. Matthay. 2003. Cytokine-mediated inflammation in acute lung injury. Cytokine & Growth Factor Reviews 14: 523-535. (Pubitemid 37296025)
20. Ricard, J.D., D. Dreyfuss, and G. Saumon. 2001. Production of inflammatory cytokines in ventilator-induced lung injury: A reappraisal. American Journal of Respiratory and Critical Care Medicine 163: 1176-1180. (Pubitemid 32378457)
21. Park, W.Y., R.B. Goodman, K.P. Steinberg, J.T. Ruzinski, F. Radella 2nd, et al. 2001. Cytokine balance in the lungs of patients with acute respiratory distress syndrome. American Journal of Respiratory and Critical Care Medicine 164: 1896-1903. (Pubitemid 33152327)
22. Gajic, O., M.A. Gropper, and R.D. Hubmayr. 2006. Pulmonary edema after transfusion: how to differentiate transfusion-Associated circulatory overload from transfusion-related acute lung injury. Critical Care Medicine 34: S109-S113. (Pubitemid 43670476)
23. Zhao, X., J.W. Zmijewski, E. Lorne, G. Liu, Y.J. Park, et al. 2008. Activation of AMPK attenuates neutrophil proinflammatory activity and decreases the severity of acute lung injury. American Journal of Physiology. Lung Cellular and Molecular Physiology 295: L497-L504.
24. Mabley, J., S. Gordon, and P. Pacher. 2011. Nicotine exerts an anti-inflammatory effect in a murine model of acute lung injury. Inflammation 34: 231-237.
25. El Kebir, D., L. Jozsef, W. Pan, and J.G. Filep. 2008. Myeloperoxidase delays neutrophil apoptosis through CD11b/CD18 integrins and prolongs inflammation. Circulation Research 103: 352-359.
26. Chen, Z., X. Zhang, X. Chu, K. Song, Y. Jiang, et al. 2010. Preventive effects of valnemulin on lipopolysaccharide-induced acute lung injury in mice. Inflammation 33: 306-314.
27. Fukunaga, K., P. Kohli, C. Bonnans, L.E. Fredenburgh, and B.D. Levy. 2005. Cyclooxygenase 2 plays a pivotal role in the resolution of acute lung injury. Journal of Immunology 174: 5033-5039.
28. Christman, J.W., R.T. Sadikot, and T.S. Blackwell. 2000. The role of nuclear factor-kappa B in pulmonary diseases. Chest 117: 1482-1487. (Pubitemid 30321607)
29. Wright, J.G., and J.W. Christman. 2003. The role of nuclear factor kappa B in the pathogenesis of pulmonary diseases: implications for therapy. American Journal of Respiratory Medicine 2: 211-219. (Pubitemid 36869436)
30. Karin, M., and Y. Ben-Neriah. 2000. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annual Review of Immunology 18: 621-663. (Pubitemid 30365393)
31. Karin, M. 1999. The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation. Journal of Biological Chemistry 274: 27339-27342. (Pubitemid 29457970)